Latest News Archive

Please select Category, Year, and then Month to display items

Shimlas set to go head-to-head with Ikeys in the Varsity Cup final

19 April 2024 | Story Anthony Mthembu | Photo Francois van Vuuren

Varsity Cup Shimlas — The FNB UFS Shimlas are confident to emerge victorious as they prepare to go against the FNB UCT Ikeys in FNB Varsity Cup final.

The FNB UFS Shimlas are confident of securing a win in the 2024 FNB Varsity Cup final as they prepare to take on the FNB UCT Ikeys at the University of the Free State (UFS) Shimla Park in Bloemfontein on 22 April 2024 at 19:00.

This marks the first time since 2015 that the final is being hosted at Shimla Park. As such, the Shimlas hope to use this home ground advantage to emerge victorious.

Prof Francis Petersen, Vice-Chancellor and Principal of the UFS, says he commends each player for their dedication, resilience, and sportsmanship throughout the season. “I will be cheering on the team – their efforts and commitment have already made us proud, and we look forward to supporting them on home ground. We are also immensely grateful to the coaching team for their support to the Shimlas. Good luck to the team, and know that every fellow Kovsie is behind you,” says Prof Petersen.

The Shimlas advanced to the final after a 38-24 win over the FNB Maties in the semi-finals held at the Danie Craven Stadium in Stellenbosch on 15 April 2024. According to André Tredoux, Head Coach of the FNB UFS Shimlas, this is a tremendous win for the team, as the FNB Maties have only lost ten times in the history of the FNB Varsity Cup when playing at home. In addition, he credits Assistant Coaches Melusi Mthethwa and Tiaan Liebenberg’s hard work for the success of the team up to this point.

The mindset of the UFS Shimlas heading into the final

According to Tredoux, the team assumes a new approach and mindset in preparation for each game. In the semi-finals, the team adopted the motto ‘breathe to succeed’, which helped align the focus and attitude of the team in the game. However, as the final approaches, he indicates that, “The big thing going into a final is to stick to our processes with our intensity, and then also for the medical team and the strength and conditioning team to get the team healthy”.

In addition, Tredoux encourages the UFS community to show up in their numbers to support the FNB UFS Shimlas. “The technical team will have a good plan and the players are ready to play with everything for the Cup. We have the firepower to do it with the support of the Kovsie students,” Tredoux expressed. He also highlights that those in attendance can expect a great atmosphere and some ‘awesome rugby’. This is because the FNB UFS Young Guns will also battle the FNB NWU Young Guns at Shimla Park on 22 April 2024 from 15:30.

Those interested in seeing any of this action can still purchase their tickets on the Varsity Cup website here.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept